STREPTOCOCCUS AGALACTIAE CARRIAGE RATE AMONG WOMEN OF CHILDBEARING AGE AND ITS ROLE IN THE DEVELOPMENT OF CONGENITAL INFECTIONS: PRELIMINARY RESULTS OF A PILOT STUDY

Tracheobronchial aspirate samples for PCR were obtained from 78 newborns with intrauterine pneumonia to verify the disease etiology. It was found that in 11.5% of cases congenital pneumonia was caused by Streptococcus agalactiae (S. agalactiae).  PCR test of pap smears obtained from 401 women (aged from 17 to 35 years) found the genome of S. agalactiae in 19.5% of cases. In 31 of the 78 infected women (39.7%), carriage of S. agalactiae was asymptomatic, characterized by the absence of complaints or any clinical or laboratory manifestations of the inflammatory process. The high S. agalactiae infection level in reproductiveage women and its role in the etiology of congenital infection determines the need for compulsory screening of pregnant women for S. agalactiae and antibiotic prophylaxis of perinatal S. agalactiae infection.

1. Boyer KM. Neonatal group В streptococcal infections. Current Opinion Pediatrics, 1995, 7: 13-18.

2. Шабалов Н.П. Внутриутробные инфекции. Неонатология. В 2 тт. СПб.: Специальная литература, 1996, 2: 43-76.

3. Baltimore RS, Huie SM, Meek JI, Schuchat A. Early-onset neonatal sepsis in the era of group В streptococcal prevention. Pediatrics, 2001, 108: 1094-8.

4. Centers for Disease Control and prevention (CDC). Prevention of perinatal group В streptococcal disease: Revised Guidelines from CDC. Morb. Mortal. Wkly Rep., 2002, 51: 10-22.

5. Jacobsson K. A Novel family of fibrinogen-binding proteins in Streptococcus agalactiae. Vet. Microbiol., 2003, 96: 103-113.

6. Weisner AM, Johnson AP, Lamagni TL et al. Characterization of group В streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis, 2004, 38: 1203-1208.

7. Nandyal RR. Update on group B streptococcal infections: perinatal and neonatal periods. J Perinat Neonatal Nurs, 2008, 22(3): 230-37.

8. Barcaite E et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet. Gynecol. Scand., 2008, 87: 260-271.

9. Bergseng H, Rygg M, Bevanger L et al. Invasive group B streptococcus (GBS) disease in Norway 1996-2006. Eur J Clin Microbiol Infect Dis, 2008, 27: 1193-1199.

10. Заплатников А.Л., Садова Н.В., Шипулина О.Ю. и др. Инфекция Streptococcus agalactiae: современные возможности диагностики, профилактики и лечения. Вопросы практической педиатрии, 2011, 2: 90-93.

11. Group B streptococcal infections. Red Book: 2015. Report of the Committee on Infection Diseases. Ed Kimberlin DW, 30th ed., Elk Grove Village, IL: American Academy of Pediatrics, 2015: 745-750.

12. Ballard MS, Schønheyder HC, Knudsen JD et al. The changing epidemiology of group B streptococcus bloodstream infection: a multinational population-based assessment. Infect Dis, 2016 May, 48(5): 386-91.

13. Оганян К.А. Течение и исход беременности при колонизации мочеполового тракта женщин стрептококками группы В и D: Автореф. дисс. … канд. мед. наук. СПб., 2008.

14. Сафонова А.П., Пиксасова О.В., Скачкова Т.С. и др. Разработка методики выявления и количественного определения ДНК Streptococcus agalactiae на основе ПЦР в режиме реального времени. II ежегодный Всероссийский конгресс по инфекционным болезням. М., 2010: 282.